Bone Biologics Inc.
This article was originally published in Start Up
Executive Summary
Bone Biologics' protein for stimulating bone growth was originally isolated from areas of active bone growth in humans. Based on animal studies to date, the company's founders claim that its UCB-1, performs as well if not better than marketed BMPs because of its molecular specificity. The company plans to combine UCB-1 with a proprietary scaffold to create biological solutions to a number of bone disorders.